New Product Planning

Evaluating the Viability of Assets

Successfully bringing a new product to market requires a solid strategic foundation, and the agility to refine the plan as circumstances evolve.

Connecting Product Development to Commercial Success

Life sciences organizations often struggle because they lack a strong strategic foundation that connects new product development decisions with long-term commercial success. Many face uncertainty translating clinical and scientific potential into differentiated value, limited visibility into evolving market dynamics and stakeholder needs, and challenges in determining which data or scenarios should guide decision-making.

Without an integrated approach that blends market research, forecasting, and analytics, organizations risk misaligned strategies, inefficient investments, and missed opportunities to position brands for lasting impact.

Shaping Early Asset Strategy

Trinity’s New Product Planning (NPP) projects help clients develop assets that resonate in the market. Our suite of offerings identifies unmet needs among market stakeholders and shapes strategies to optimize products, using cost-effective and stage-appropriate rigor. New project planning provides a solid foundation early commercialization teams can build upon as development progresses.

There is no room for missteps when evaluating the viability of assets in early development. Go/no go decisions demand clear answers to a range of critical questions across the early asset lifecycle.

Asset Evaluation

What are the critical questions along the asset evaluation journey?

Indication Selection

How do you identify which indication to prioritize to maximize value?

Stakeholder Engagement

How do you engage internal stakeholders effectively?

Regional Strategy

When and how should regional differences factor into the process?

Our Impact

Treatment Driver Identification: Pinpoint the product attributes and endpoints that will most influence evolving treatment selection.
Competitive Benchmark Awareness: Define the minimum performance thresholds your product must achieve to drive clinician adoption.
Market Trajectory Forecast: Anticipate how projected market share changes with product performance, including inflection points and diminishing returns.
Investment Viability: Establish the product profile needed to meet financial expectations and investment hurdles.
Analytics Approach: Generate smart, lean insights and analytics for a new asset

Integrated Expertise & Insights

Trinity’s NPP offering is designed to address unique client needs and drive long-term success. With expertise in building commercial understanding, informing development plans, and articulating areas of uncertainty, we serve asa reliable partner at every stage.

By integrating primary market research, analytics, and strategic forecasting, our approach combines best-in-class methods and tools with advisory services to ensure strategy remains central from the early stages of product development. Bringing together secondary research, real-world evidence, and primary research— including clinicians and payers—minimizes risk in early asset development decisions.